Harnessing the Potential of Human iPSC‐derived Microglia‐like Cells as Antigen Presenting Cells for MAIT Cells to Study AD Pathology

Reham Afify, Randy R Brutkiewicz · 2025

Read Harnessing the Potential of Human iPSC‐derived Microglia‐like Cells as Antigen Presenting Cells for MAIT Cells to Study AD Pathology by Reham Afify, Randy R Brutkiewicz (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710242.txt.

Description

Reham Afify and Randy R Brutkiewicz present a 2025 study plan on immune cells and Alzheimer disease. Microglia, the brain's resident immune cells, show microbial parts to a T cell type called MAIT cells. Past mouse work by the team tied that pathway to harm in Alzheimer disease. The new work asks how the pathway acts in human cells.

The plan grows microglia-like cells from human stem cells of healthy donors. The cells will meet E coli bacteria, and activation will be read from a signal protein. Mixed cultures with MAIT cells will then test whether the pathway switches those cells on. The authors expect both signals to rise. They call the setup a first of its kind for human MAIT studies.

Catalog record

CREATORReham Afify, Randy R Brutkiewicz
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11710242

Browse the full library · About the Tower of Babel